15,848
Views
44
CrossRef citations to date
0
Altmetric
Invited Review Articles

A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients

, , &
Pages 415-431 | Received 23 Apr 2020, Accepted 22 May 2020, Published online: 22 Jun 2020

References

  • Protocol on Prevention and Control of COVID-19 (Edition 6) under National Health Commission People’s Republic of China, Resources. 2020. Available from: http://en.nhc.gov.cn/2020-03/29/c_78468.htm
  • Weinkove R, McQuilten Z, Adler J, et al. Haematology & Oncology COVID-19 interim guidance version 3.0. Haematol Soc Aust New Zeal. 2020. Available from: https://www.hsanz.org.au/Haematology&OncologyCOVID-19InterimGuidanceVersion3.019thMarch2020.pdf
  • Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Cent Dis Control. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
  • Aylward B (WHO); Liang W (PRC). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February 16–24, 2020. WHO-China Jt Mission Coronavirus Dis 2019. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
  • Huang J, Cheng A, Lin S, et al. Individualized prediction nomograms for disease progression in mild COVID-19. J Med Virol. 2020. DOI:10.1002/jmv.25969
  • Hu L, Chen S, Fu Y, et al. Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China. Clin Infect Dis. 2020. DOI:10.1101/2020.03.25.20037721
  • Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1713.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
  • Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
  • Song C-Y, Xu J, He J-Q, et al. COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients. medRxiv. 2020. DOI:10.1101/2020.03.05.20031906
  • Lo IL, Lio CF, Cheong HH, et al. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau. Int J Biol Sci. 2020;16(10):1698–1707.
  • Chen J, Qi T, Liu L, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020. DOI:10.1016/j.jinf.2020.03.004
  • Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269.
  • Wu F, Zhao S, Yu B, et al. Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. bioRxiv. 2020. DOI:10.1101/2020.01.24.919183
  • Qu R, Ling Y, Zhang Y-H, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19. J Med Virol. 2020. DOI:10.1002/jmv.25767
  • Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020. DOI:10.1007/s11427-020-1661-4
  • Lin Y, Ji C, Weng W, et al. Epidemiological and clinical characteristics of 124 elderly outpatients with COVID-19 in Wuhan, China. Lancet. 2020. DOI:10.2139/ssrn.3543596
  • Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa248
  • Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020. DOI:10.1515/cclm-2020-0198
  • Wang K, Zuo P, Liu Y, et al. Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China. Clin Infect Dis. 2020. DOI:10.1093/cid/ciaa538
  • Shi Y, Tan M, Chen X, et al. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. medRxiv. 2020. DOI:10.1101/2020.03.12.20034736
  • Yu H, Yu H, Yu H, et al. Total protein as a biomarker for predicting coronavirus disease-2019 pneumonia. Lancet. 2020. DOI:10.2139/ssrn.3551289
  • Li Q, Ding X, Xia G, et al. A simple laboratory parameter facilitates early identification of COVID-19 patients. medRxiv. 2020. DOI:10.1101/2020.02.13.20022830
  • Shoenfeld Y, Gurewich Y, Gallant LA, et al. Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am J Med. 1981;71(5):773–778.
  • Qian G-Q, Yang N-B, Ding F, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. J Chem Inf Model. 2012;53(9):1689–1699.
  • Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 death cases with COVID-19. medRxiv. 2020. DOI:10.1101/2020.02.26.20028191
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
  • Zheng H-Y, Zhang M, Yang C-X, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17(5):541–543.
  • Ai J, Zhang HH-YH-C, Xu T, et al. Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China. medRxiv. 2020. DOI:10.1101/2020.02.13.20022673
  • Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;2600(20):1–7.
  • Wang Y, Lu X, Chen H, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020. DOI:10.1164/rccm.202003-0736LE
  • Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368(January):1–7.
  • Zhang G, Hu C, Luo L, et al. Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. medRxiv. 2020. 2020.03.02.20030452.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;6736(20):1–9.
  • Ding Q, Lu P, Fan Y, et al. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020. DOI:10.1002/jmv.25781
  • Zheng Y, Huang Z, Yin G, et al. Study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting other factors besides uncontrolled inflammation contributed to multi-organ injury. medRxiv. 2020. DOI:10.1101/2020.02.19.20024885
  • Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020. DOI:10.1016/j.kint.2020.03.005
  • Liao J, Fan S, Chen J, et al. Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults. medRxiv. 2020. DOI:10.1101/2020.03.10.20032136
  • Chen X, Ling J, Mo P, et al. Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients. medRxiv. 2020. DOI:10.1101/2020.03.03.20030437
  • Tabata S, Imai K, Shuichi Kawano MI, et al. Non-severe vs severe symptomatic COVID-19: 104 cases from the outbreak on the cruise ship “Diamond Princess” in Japan. medRxiv. 2020. DOI:10.1101/2020.03.18.20038125
  • Wang Y, Wang Y, Chen Y, et al. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568–561.
  • Cheng SC, Chang YC, Fan Chiang YL, et al. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. J Formos Med Assoc. 2020;119(3):747–751.
  • Zhang J. J, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol. 2020. DOI:10.1111/all.14238
  • Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):1–4.
  • Tan L, Kang X, Ji X, et al. Validation of reported risk factors for disease classification and prognosis in COVID-19: a descriptive and retrospective study. medRxiv. 2020;21(1):1–9.
  • Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. medRxiv. 2020. DOI:10.1101/2020.03.01.20029074
  • Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med. 2020. DOI:10.1164/rccm.202003-0543OC
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
  • Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–148.
  • Kim JK, Jeon J-S, Kim JW, et al. Correlation between abnormal platelet count and Respiratory viral infection in patients from Cheonan, Korea. J Clin Lab Anal. 2016;30(3):185–189.
  • Gong J, Ou J, Qiu X, et al. A Tool to early predict severe 2019-novel coronavirus pneumonia (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. medRxiv. 2020. DOI:10.1101/2020.03.17.20037515
  • Zheng X, Chen J, Deng L, et al. Clinical features and risk factors for the severity of inpatients with COVID-19: a retrospective cohort study. SSRN Electron J. 2020. DOI:10.2139/ssrn.3562460
  • Yang A, Liu J, Tao W, et al. The diagnostic and predictive role of in COVID-19 patients NLR, d-NLR and PLR. Int Immunopharmacol. 2020;84:106504.
  • Feng Z, Yu Q, Yao S, et al. Early prediction of disease progression in 2019 novel coronavirus pneumonia patients outside Wuhan with CT and clinical characteristics. medRxiv. 2020. DOI:10.1101/2020.02.19.20025296
  • Yang P, Ding Y, Xu Z, et al. Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China. medRxiv. 2020. DOI:10.1101/2020.02.28.20028068
  • Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206.
  • Chandra S, Tripathi AK, Mishra S, et al. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus. 2012;28(3):144–146.
  • Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020. DOI:10.1111/aogs.13867
  • Liu H, Liu F, Li J, et al. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect. 2020. DOI:10.1016/j.jinf.2020.03.007.
  • Li N, Han L, Peng M, et al. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study. medRxiv. 2020. DOI:10.1101/2020.03.10.20033605
  • Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815.
  • Chen Y, Peng H, Wang L, et al. Infants born to mothers with a new coronavirus (COVID-19). Front Pediatr. 2020. DOI:10.3389/fped.2020.00104
  • Liu D, Li L, Zheng D, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol. 2020. DOI:10.2214/ajr.20.23072
  • Ma H, Hu J, Tian J, et al. Visualizing the novel coronavirus (COVID-19) in children: what we learn from patients at Wuhan Children’s Hospital. 2020. Available from: https://ssrn.com/abstract=3550012
  • Tang A, Xu W, Shen M, et al. A retrospective study of the clinical characteristics of COVID-19 infection in 26 children. Block Caving – A Viable Altern. 2020;21(1):1–9. Available from: https://www.golder.com/insights/block-caving-a-viable-alternative/
  • Rahimzadeh G, Ekrami Noghabi M, Kadkhodaei Elyaderani F, et al. COVID-19 infection in Iranian children: a case series of 9 patients. J Pediatr Rev. 2020. DOI:10.32598/jpr.8.2.139
  • Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(4):502–504.
  • Sun D, Li H, Lu XX, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World J Pediatr. 2020. DOI:10.1007/s12519-020-00354-4
  • Qiu H, Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;2019(20):1–8.
  • Yan L, Zhang H, Ph D, et al. Prediction of criticality in patients with severe Covid-19 infection using three clinical features:a machine learning-based prognostic model with clinical data in Wuhan. medRxiv. 2020. DOI:10.1101/2020.02.27.20028027
  • Yuan H, Yuan H, Yuan H, et al. A current emerging respiratory infection: epidemiological and clinical characteristics, diagnosis and treatments of COVID-19. Lancet. 2019. DOI:10.2139/ssrn.3551344
  • Yang M, Li CK, Li K, et al. Hematological findings in SARS patients and possible mechanisms (review). Int J Mol Med. 2004;14(2):311–315.
  • Briggs C, Kunka S, Hart D, et al. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol. 2004;126(1):93–99.
  • Tian S, Zhu X, Sun X, et al. Longitudinal analysis of laboratory findings during the process of recovery for patients with COVID-19. medRxiv. 2020. DOI:10.1101/2020.04.04.20053280
  • De La R, Phd R, Borges M, et al. Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study. medRxiv. 2020. DOI:10.1101/2020.05.07.20094987
  • McCranor BJ, Kim MJ, Cruz NM, et al. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis. 2014;52(2–3):126–133.
  • Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020;2019:39–45.
  • Zini G, Bellesi S, Ramundo F, et al. Morphological anomalies of circulating blood cells in COVID-19. Am J Hematol. 2020. DOI:10.1002/ajh.25824
  • Zhang D, Guo R, Lei L, et al. COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome. medRxiv. 2020. DOI:10.1101/2020.03.24.20042655
  • Chhabra G. Automated hematology analyzers: recent trends and applications. J Lab Physicians. 2018;10(1):15–16.
  • Li J, Zhang Y, Wang F, et al. Sex differences in clinical findings among patients with coronavirus disease 2019 (COVID-19) and severe condition. medRxiv. 2020. DOI:10.1101/2020.02.27.20027524
  • Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422.